Pegasta Injection
Prescription Required
Product introduction
Pegasta Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates bone marrow to produce white blood cells. These cells protect the body against infections.
Pegasta Injection is used after cancer treatment, if the level of white blood cells is too low, used to increase blood stem cells in the body or used after a bone marrow transplant
Pegasta Injection is used after cancer treatment, if the level of white blood cells is too low, used to increase blood stem cells in the body or used after a bone marrow transplant
Uses of Pegasta Injection
- Prevention of Infections after chemotherapy
Benefits of Pegasta Injection
In Prevention of Infections after chemotherapy
Pegasta Injection increases the production of white blood cells by stimulating the immune system in our body. White blood cells are those cells that help us to fight infections. This medicine is really effective and must be used under medical supervision. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.
Side effects of Pegasta Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Pegasta
- Bone pain
- Joint pain
- Headache
- Nausea
- Low blood platelets
- Muscle pain
- Back pain
- Pain in extremities
- Injection site pain
How to use Pegasta Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Pegasta Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Pegasta Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Pegasta Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
SAFE
Pegasta Injection does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Pegasta Injection is safe to use in patients with kidney disease. No dose adjustment of Pegasta Injection is recommended.
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Pegasta Injection in patients with liver disease. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Pegasta Injection
₹10300.0/Injection
Peggrafeel 6mg Injection
Dr Reddy's Laboratories Ltd
₹3010/injection
71% cheaper
Pegstim Injection
Zydus Cadila
₹4339/injection
58% cheaper
Pegex 6mg Injection
Emcure Pharmaceuticals Ltd
₹4173/injection
59% cheaper
Lupifil P 6mg Injection
Lupin Ltd
₹4172/injection
59% cheaper
Imupeg 6mg Injection
Abbott L
₹6984.45/injection
32% cheaper
Quick tips
- Pegasta Injection reduces the risk of infection in people treated with chemotherapy.
- It is usually given as a daily injection into the tissue just under the skin or into the vein.
- You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
- Store it in the refrigerator, protect it from light, and don't shake it.
- For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
- Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
- Use caution while driving or doing anything that requires concentration as Pegasta Injection may cause dizziness.
- Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment with this medicine.
- Stop taking Pegasta Injection and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.
Fact Box
Chemical Class
Granulocyte Colony-Stimulating Factor
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Granulocyte-colony stimulating factor (G-CSF)
Patient concerns
User feedback
Patients taking Pegasta Injection
Once A Month
58%
Once A Day
31%
Once A Week
7%
Twice A Day
3%
Twice A Month
2%
What are you using Pegasta Injection for?
Infections af*
89%
Others
11%
*Infections after chemotherapy
How much was the improvement?
Average
44%
Poor
33%
Excellent
22%
What were the side-effects while using Pegasta Injection?
Bone pain
100%
How do you take Pegasta Injection?
With or witho*
100%
*With or without food
FAQs
What is Pegasta Injection? How is it given?
Pegasta Injection belongs to a class of medications called colony stimulating factors. It helps reduce the chances of infections and side effects related to chemotherapy and does not directly treat cancer. It comes as a solution (liquid) to inject subcutaneously (under the skin), 24 hours after chemotherapy. It may be injected by a doctor/nurse in a hospital or you may be shown how to use injections at home
How does pegfilgrastim work?
Pegfilgrastim belongs to a class of medications called colony stimulating factors. It acts on hematopoietic cells (cells in the bone marrow that produce red blood cells, white blood cells, and platelets) to increase production of neutrophils (a type of white blood cell) in the body.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Masters SB. Agents Used in Anemias; Hematopoetic Growth Factors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 581.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1074-75.
- Pegfilgrastim. Cambridge, UK: Amgen Ltd.; 2002 [revised Sep. 2018]. [Accessed 28 Jan 2019] (online) Available from:
- Medscape. Pegfilgrastim. [Accessed 26 Mar. 2019] (online) Available from:
Marketer details
Name: Intas Pharmaceuticals Ltd
Address: Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
11 people bought this recentlyMRP
₹10300
Inclusive of all taxes
0.6 ml in 1 prefilled syringe
SOLD OUT
Notify me